CTLT 63.48 (+0%)
US1488061029• Drug Manufacturers• Drug Manufacturers - Specialty & Generic
Intro Stories Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. CTLT

Catalent (CTLT) Stories

Here is a selected set of our story library related to Catalent (CTLT).

Post

Catalent (CTLT) - Piotroski F-Score Analysis for Year 2023 (Final Score: 2/9)

Catalent (CTLT) Piotroski F-Score Analysis 2023 reveals a final score of 2/9, highlighting concerns in profitability, liquidity, and operating efficiency.

2024-06-05